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As several hundred people on two
continents bring class action lawsuits
against various airlines for ‘ignoring’
warnings about the dangers of deep
vein thrombosis (DVT), clinics offering
genetic predisposition tests are
springing up.
Two of the first countries to offer
blood screening in major cities are South
Africa and the United States, while the
lawsuits are being launched in Australia
and the United Kingdom.
Although debate still rages about the
general quantum of risk in what is
commonly called ‘economy class
syndrome’, it is accepted that a positive
family history or previous episodes of
DVT requires serious attention.
Categories of passengers who may
benefit most from the new tests include
smokers, diabetics, pregnant and/or
obese people, and those with high blood
pressure or taking oral contraceptives. 
One genetic expert who suddenly and
unwittingly found himself at the centre
of both lawsuits, 35 years after penning
two scientific articles warning about
DVT, is Peter Beighton, Emeritus
Professor of Human Genetics at UCT.
Beighton has been put ‘on standby’
by lawyers for the DVT plaintiffs, after
writing in the May 1967 issue of the
British Heart Journal that ‘the stasis of a
long journey, combined with pressure
from the aircraft at the back of the legs
and the hypoxia, together provide an
ideal climate for precipitating DVT’.
The alleged failure of the airline
industry to warn long-distance
travellers of this, lies at the heart of the
litigation.
Beighton remarked wryly that he
‘moved by chance out of internal
medicine into human genetics and gave
no further thought to DVT or
pulmonary embolism for over 30 years -
until I got that phonecall in 2001’.
While ‘surprised at how slowly things
are moving,’ he believes the nascent
genetic testing industry will burgeon.
‘The popular press alarmed travellers,
but the risks are real,’ he told the SAMJ.
Beighton has been interviewed for the
popular British television show
‘Panorama’ about his unwitting role in
the civil suits.
He told the SAMJ that he became
interested in the medical hazards of air
travel while serving first as a
paratrooper in the RAMC, and then
with UN peacekeeping forces in the
Congo, and afterwards as a medical
registrar at Hillingdon Hospital near
Heathrow Airport. These influences led
him to penning his first article on ‘the
medical hazards of air travel’, in The
Practitioner in May 1967.
‘I basically analysed the causes of
morbidity and mortality of people
coming from the airport, mainly
cardiovascular problems and
unconsciousness. In the second article in
the British Heart Journal, my co-author
Peter Richards was a medical officer at
London Airport and also a British Army
Congo veteran’.
In this article, both men formally
acknowledged the then British
European Airways (short-haul) and
British Overseas Airways (long-haul)
and Dr J Graham Taylor, the airline
company’s director of medical services
at Heathrow Airport - a fact seized
upon by the litigators.
Beighton is one of the first academics
to suggest the idea of genetic screening
for a propensity to DVT and he says the
launching of the service nationally in
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the United States has validated the local
decision. ‘They both came to the same
conclusion independently,’ he stated.
He says initial airline studies (one by
Gauteng’s Professor Barry Jacobsen) are
finding that the incidence of DVTs is
fairly low (low generalised overall risk)
but that because of the large numbers of
people flying, a ‘fair number of people
are suffering DVT’.
‘If your other risk factors are there,
you’d be well advised to take the test.
The chances of it being positive are very
small, but if you do have DVT, the
complications could be lethal.’
Beighton drew a parallel with
cigarette manufacturers printing health
warnings. ‘If you knew you had the
gene that predisposes you to lung
cancer, you’d probably stop smoking.
Equally, a person who knows that he or
she has an increased risk of DVT is
likely to pay attention to the various
pre-flight and in-flight measures which
are now proposed’.
However Professor Barry Jacobsen,
head of haematology for the National
Health Laboratory Services and the
chief at the Wits surgical research unit,
was openly sceptical of genetic testing
for DVT predisposition in the absence of
hard scientific findings.
‘There’s no way you can say outright
that if you have the genetic risk factor
that you will get a thrombosis. If you
don’t have the risk factor, that doesn’t
protect you from thrombosis - a person
will just get information that won’t help
them’. He considers that the jury is still
out on the issue.
Jacobsen led a team that studied 900
SAApassengers flying between
Johannesburg and London in April and
May 2002, taking blood samples before
departure and upon landing, with 60%
having ultrasound done after their
flights. DNAsamples were also taken.
SAA donated 5 000 Voyager miles to
each volunteer and major technical and
pathology companies donated staff and
equipment.
He said the Medical Research Council
was still analysing the data at the time
of this report and that he hoped to have
a paper written ‘within six weeks -
depending on other variables’.
‘You’re going to end up with a lot of
passengers claiming it’s SAA’s
responsibility to upgrade them to
business class where there’s more room
- but that’s not SAA’s responsibility...
Let’s not forget that President Richard
Nixon got a clot flying in Airforce One
to Russia - and he had a fair bit of
legroom,’ he quipped.
Dr Maritha Kotze, a molecular
geneticist whose company at the
Christian Barnard Memorial Hospital is
conducting leiden factor five mutation,
pro-thrombin gene variant and the more
controversial elevated homocysteine
tests, says the local service is far cheaper
than in the USA. ‘They’re charging the
equivalent of R2 450 for just doing the
first two factors and we’re charging
R900 for three.’
She said she was preparing for a large
influx of tests, after the SAANetcare
travel clinics asked for more test request
forms to be printed.
‘What I’d say to our critics is that if
you have genetic factors, you are at risk
and travelling anywhere with stasis for
longer than three hours becomes
relevant’.
Kotze claims the presence of elevated
homocysteine increases the indicator
accuracy by a factor of eight, a claim
that is disputed by some geneticists
who believe the third test to be
unwarranted.
Many gynaecologists are warning
women who test positive for any of the
three DVT predisposing factors, to stop
taking the contraceptive pill. Jacobsen
entirely agrees with this but says it’s ‘a
separate issue’.
Dr Stephen Toovey, a director of SAA
Netcare’s nine travel clinics that all offer
the service, says clients are asked for
family and personal histories before
blood samples are taken. Results are
available within two to three days.
‘Depending on the result, we have a
network of cardiologists and vascular
surgeons for referrals. This doesn’t only
impact on travelling, it can warn clients
of surgical and other risks too.’
He said he was unaware of any other
travel clinics offering the service in
South Africa. The local service began in
November 2002, shortly before the
United States began setting up.
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‘The press has alarmed
travellers, but the real risk 
is real!’
‘President Richard Nixon
got a clot flying in Airforce 1
to Russia - and he had a fair
bit of leg-room’.
Dr Maritha Kotze
